3rd Oct 2019 16:38
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i | ||||||
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are at- tachedii: |
Amryt Pharma PLC | |||||
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) | ||||||
Non-UK issuer | ||||||
2. Reason for the notification (please mark the appropriate box or boxes with an "X") | ||||||
An acquisition or disposal of voting rights | ||||||
An acquisition or disposal of financial instruments | ||||||
An event changing the breakdown of voting rights | ||||||
Other (please specify)iii: Intra group transfer | X | |||||
3. Details of person subject to the notification obligationiv | ||||||
Name | Athyrium Funds GP Holdings LLC | |||||
City and country of registered office (if applicable) | Delaware, USA | |||||
4. Full name of shareholder(s) (if different from 3.)v | ||||||
Name | Athyrium Opportunities II Acquisition LP, Athyrium Opportunities II Acquisition 2 LP, Athyrium Opportunities III Acquisition LP, and Athyrium Opportunities III Acquisition 2 LP | |||||
City and country of registered office (if applicable) | Delaware, USA | |||||
5. Date on which the threshold was crossed or reachedvi: | 24/9/2019 | |||||
6. Date on which issuer notified (DD/MM/YYYY): | 26/9/2019 | |||||
7. Total positions of person(s) subject to the notification obligation | ||||||
% of voting rights at- tached to shares (to- tal of 8. A) | % of voting rights through financial instru- ments (total of 8.B 1 + 8.B 2) |
Total of both in % (8.A + 8.B) | Total number of voting rights of is- suervii | |||
Resulting situation on the date on which threshold was crossed or reached |
27.2% |
0 |
27.2% |
157,718,438 | ||
1
Position of previous notification (if applicable) |
27.2% |
0 |
27.2% |
8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii | |||||||||
A: Voting rights attached to shares | |||||||||
Class/type of shares ISIN code (if possible) | Number of voting rightsix | % of voting rights | |||||||
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) | Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) | Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) | Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) | ||||||
GB00BKLTQ412 | 0 | 42,883,097 | 0 | 27.2% | |||||
SUBTOTAL 8. A | 42,883,097 | 27.2% | |||||||
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) | |||||||||
Type of financial in- strument |
Expiration datex |
Exercise/ Conversion Periodxi | Number of voting rights that may be acquired if the instrument is exercised/converted. |
% of voting rights | |||||
SUBTOTAL 8. B 1 | |||||||||
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) | |||||||||
Type of financial instrument | Expiration datex | Exercise/ Conversion Pe- riod xi | Physical or cash settlementxii | Number of voting rights |
% of voting rights | ||||
SUBTOTAL 8.B.2 | |||||||||
9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") | ||||
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii | ||||
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary) |
X | |||
Namexv | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial in- struments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold | |
Jeffrey Ferrell | 27.2% | 0 | 27.2% | |
Athyrium Funds GP Holdings LLC | 27.2% | 0 | 27.2% | |
Athyrium GP Holdings LLC | 15.8% | 0 | 15.8% | |
Athyrium Opportunities Associates II LP | 15.8% | 0 | 15.8% | |
Athyrium Opportunities II Acquisition LP | 0 | 0 | 0 | |
Jeffrey Ferrell | 27.2% | 0 | 27.2% | |
Athyrium Funds GP Holdings LLC | 27.2% | 0 | 27.2% | |
Athyrium GP Holdings LLC | 15.8% | 0 | 15.8% | |
Athyrium Opportunities Associates II LP | 15.8% | 0 | 15.8% | |
Athyrium Opportunities II Acquisition 2 LP | 15.8% | 0 | 15.8% | |
Jeffrey Ferrell | 27.2% | 0 | 27.2% | |
Athyrium Funds GP Holdings LLC | 27.2% | 0 | 27.2% | |
Athyrium Opportunities Associates III GP LLC | 11.4% | 0 | 11.4% | |
Athyrium Opportunities Associates III LP | 11.4% | 0 | 11.4% | |
Athyrium Opportunities III Acquisition LP | 0 | 0 | 0 | |
Jeffrey Ferrell | 27.2% | 0 | 27.2% |
Athyrium Funds GP Holdings LLC | 27.2% | 0 | 27.2% |
Athyrium Opportunities Associates III GP LLC | 11.4% | 0 | 11.4% |
Athyrium Opportunities Associates III LP | 11.4% | 0 | 11.4% |
Athyrium Opportunities III Acquisition 2 LP | 11.4% | 0 | 11.4% |
10. In case of proxy voting, please identify: | |||
Name of the proxy holder | |||
The number and % of voting rights held | |||
The date until which the voting rights will be held | |||
11. Additional informationxvi | |||
All shares held by Athyrium Opportunities II Acquisition LP were transferred to Athyrium Opportunities II Acquisition 2 LP such that Athyrium Opportunities II Acquisition 2 LP holds 15.8% All shares held by Athyrium Opportunities III Acquisition LP were transferred to Athyrium Opportunities III Acquisition 2 LP such that Athyrium Opportunities III Acquisition 2 LP holds 11.4% | |||
Place of completion | New York, NY USA |
Date of completion | 26/9/2019 |
Related Shares:
AMYT.L